Emerging Trends in Geographic Atrophy: Importance of Urgency and Functional Outcomes Impact
What biomarkers indicating risk of rapid progression should eye care providers look for in patients with geographic atrophy (GA)? Just how disruptive is GA? And what do real-world patient cases look like? To find out, host Christina Weng, MD, MBA, hears from guest Charles Wykoff, MD, PhD, about the latest data informing assessments of disease progression. Dr. Wykoff also outlines the daily effects of living with GA and shares some real-world patient cases that illustrate how GA progresses when left untreated. This is the final part of a 3-part miniseries adapted from an Evolve Medical Education webinar. This educational activity is supported by Iveric Bio. Click here to view Dr. Wykoff’s webinar event, which includes images from his talk. Want to register with Evolve Medical Education? Click here.